PRESS RELEASE published on 10/08/2024 at 11:00, 1 year 11 months ago Xybion Launches Xybion LIMS 10.0: A Modern SaaS LIMS Bringing Improved Functionalities and Efficiencies for All Labs Across Industries Xybion launches Xybion LIMS 10.0, a major milestone in the LIMS industry offering modern design, user-friendly interface, and comprehensive features for laboratory operations efficiency Efficiency Software Xybion LIMS 10.0 Laboratory Operations
PRESS RELEASE published on 10/08/2024 at 10:52, 1 year 11 months ago Total du nombre de droits de vote et du capital / Information relative au nombre total de droits de vote et d'actions composant le capital SFL communique le nombre total de droits de vote au 30 septembre 2024 et met en avant la qualité de son patrimoine immobilier et de son portefeuille de clients Droits De Vote Immobilier Clients Patrimoine SFL
PRESS RELEASE published on 10/08/2024 at 10:46, 1 year 11 months ago Original-Research: PORR AG (von Montega AG): Kaufen Montega AG stärkt Kaufempfehlung für PORR AG mit Aktienrückkaufprogramm - Unternehmensanalyse und Ausblick auf Margensteigerung und Bauindustrie Montega AG PORR AG Aktienrückkaufprogramm Margensteigerung Bauindustrie
REGULATED PRESS RELEASE published on 10/08/2024 at 10:40, 1 year 11 months ago Septembre 2024 - Déclaration sur le nombre d'actions composant le capital social et sur le nombre de droits de vote correspondant bioMérieux annonce les informations mensuelles relatives au nombre total de droits de vote et d'actions. Nombre de droits de vote théoriques : 191 139 182 Autorité Des Marchés Financiers Droits De Vote BioMérieux Actions Informations Mensuelles
PRESS RELEASE published on 10/08/2024 at 10:30, 1 year 11 months ago Aurubis AG: Aurubis boosts competitive edge at site in Stolberg Aurubis AG invests €16 million in new equipment at Stolberg site, enhancing strip production capacity, energy efficiency, and sustainability. Company strengthens competitiveness and reduces CO2 emissions Sustainability Investment Aurubis AG Stolberg Site Strip Production
PRESS RELEASE published on 10/08/2024 at 10:30, 1 year 11 months ago VAZIVA SA: [REMINDER] : Invitation webinaire actionnaires individuels le mardi 15 octobre 2024 dans le cadre de la publication des Résultats semestriels 2024 Webinaire pour actionnaires individuels le 15 octobre 2024 présentant les résultats semestriels 2024 et la stratégie de développement de VAZIVA SA en France et en Europe Stratégie Résultats Semestriels Actionnaires Webinaire VAZIVA SA
PRESS RELEASE published on 10/08/2024 at 10:17, 1 year 11 months ago FLEURY MICHON : Déclaration mensuelle des droits de vote 09 2024 Fleury Michon publie le nombre total de droits de vote et d'actions au 30 septembre 2024, conforme aux réglementations en vigueur Droits De Vote Capital Social Actions AMF Fleury Michon
PRESS RELEASE published on 10/08/2024 at 10:03, 1 year 11 months ago DEUTZ updates its growth strategy and reduces costs sustainably DEUTZ updates its growth strategy and reduces costs sustainably at Capital Markets Day in Cologne. Revenue target of €4.0 billion by 2030 with new mid-term targets defined Growth Strategy Cost Reduction Capital Markets Day DEUTZ AG Revenue Target
PRESS RELEASE published on 10/08/2024 at 10:00, 1 year 11 months ago Somagenetix AG secures CHF 10 million in Series A financing to advance lentiviral gene therapy for Chronic Granulomatous Disease (CGD) Somagenetix AG secures CHF 10 million in Series A financing to advance lentiviral gene therapy for Chronic Granulomatous Disease (CGD). Vi Partners leads the financing round alongside existing investors Schroders Capital, Zürcher Kantonalbank, and Verve Ventures Series A Financing Somagenetix AG Chronic Granulomatous Disease Vi Partners Lentiviral Gene Therapy
REGULATED PRESS RELEASE published on 10/08/2024 at 09:53, 1 year 11 months ago Nombre total d'actions et droits de vote - Septembre 2024 Communiqué sur le nombre d'actions et de droits de vote d'une société anonyme. Informations conformes aux régulations en vigueur Autorité Des Marchés Financiers Société Anonyme Droits De Vote Code De Commerce Communiqué
Published on 09/12/2026 at 02:35, 1 day 5 hours ago Gamma Resources Announces Extension of Private Placement Closing Date
Published on 09/11/2026 at 23:00, 1 day 9 hours ago Rio Grande Resources Engages Machai Capital for Investor Outreach
Published on 09/11/2026 at 21:25, 1 day 11 hours ago Algo Grande Copper Intersects 30.23 Metres Grading 1.5% CuEq, including 3.55 Metres at 9.4% CuEq and 1.2-Metre Interval at 15.8% CuEq, 100 Metres Vertical Step-Out from Historical Intersects
Published on 09/11/2026 at 17:00, 1 day 15 hours ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/12/2026 at 17:50, 14 hours 44 minutes ago New Delhi Marks UN Day for South-South Cooperation with Push to Scale Dryland Innovation Across the Global South
Published on 09/12/2026 at 07:30, 1 day 1 hour ago NAGRAVISION Secures Formula 1 Content for RTL Croatia and PRO PLUS Slovenia
Published on 09/11/2026 at 22:15, 1 day 10 hours ago Amrize Appoints Mario Gross as President of Building Envelope
Published on 09/11/2026 at 22:10, 1 day 10 hours ago Quantinuum to Participate in the Piper Sandler 5th Annual Growth Frontiers Conference
Published on 09/11/2026 at 19:44, 1 day 12 hours ago DocMorris announces final conversion price and issue size of its New Convertible Bonds due 2031
Published on 09/11/2026 at 07:00, 2 days 1 hour ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 days 1 hour ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 2 days 13 hours ago Availability of the 2026 Interim Financial Report